PDL BioPharma News
Most Popular PDL BioPharma Story
Biotech CEOs face rising fury of angry investors
The San Francisco Chronicle reports that a growing number of biotech execs have had to ward off the angry attacks of shareholder activists who protest the way they're running their companies. Read more...
Latest Headlines
- January 7, 2009
- December 22, 2008
- December 5, 2008
- August 20, 2008
- April 11, 2008
- October 2, 2007
- August 29, 2007
- August 21, 2007
- July 26, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
